STOCK TITAN

Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Amarin Corporation (NASDAQ: AMRN) has scheduled its first quarter 2025 financial results announcement and conference call for May 7, 2025. The company will release its Q1 2025 results before market opening, followed by a conference call at 8:00 a.m. ET.

The call will feature Aaron Berg, President & CEO, along with senior management team members, who will discuss the quarterly results and conduct a Q&A session.

  • U.S. Dial-in: 888-506-0062
  • International Dial-in: 973-528-0011
  • Access Code: 253130

For those unable to attend live, a replay will be available through:

  • U.S. Replay: 877-481-4010
  • International Replay: 919-882-2331
  • Replay Access Code: 52230

Investors can also access the live call through the investor relations section at www.amarincorp.com, where a replay will be posted after the event.

Loading...
Loading translation...

Positive

  • Timely financial reporting schedule indicates compliance with regulatory requirements
  • Senior management team's direct participation in Q&A suggests transparency

Negative

  • None.

News Market Reaction 1 Alert

+0.10% News Effect

On the day this news was published, AMRN gained 0.10%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

DUBLIN and BRIDGEWATER, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its first quarter 2025 results followed by Q&A on Wednesday, May 7th, 2025, at 8:00 a.m. ET.

The conference call with management will follow the release of the Company’s first quarter 2025 financial results in the pre-market hours on May 7th.

Conference Call and Webcast Information:

Access to the live call:
Go to the investor relations section of the Company's website at www.amarincorp.com
Dial in within the United States: 888-506-0062
International dial in: 973-528-0011
Access Code: 253130

Access to replay:
Dial in within the United States: 877-481-4010
International dial in: 919-882-2331
Access Code: 52230

A replay of the call will also be available through the Company's website shortly after the call.

About Amarin
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk.

Availability of Other Information About Amarin
Amarin communicates with its investors and the public using the company website (www.amarincorp.com) and the investor relations website (http://www.amarincorp.com/investor-relations), including but not limited to investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that Amarin posts on these channels and websites could be deemed to be material information. As a result, Amarin encourages investors, the media and others interested in Amarin to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Amarin’s investor relations website and may include social media channels. The contents of Amarin’s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933.

Amarin Contact Information
Investor & Media Inquiries:
Mark Marmur
Amarin Corporation plc
PR@amarincorp.com
Investor.relations@amarincorp.com


FAQ

When will Amarin (AMRN) release Q1 2025 financial results?

Amarin (AMRN) will release its first quarter 2025 financial results in the pre-market hours on Wednesday, May 7th, 2025.

How can investors join Amarin's Q1 2025 earnings call?

Investors can join Amarin's Q1 2025 earnings call on May 7th, 2025, at 8:00 a.m. ET by visiting www.amarincorp.com or dialing 888-506-0062 (US) or 973-528-0011 (International) with Access Code: 253130.

What is the replay access code for Amarin's Q1 2025 earnings call?

The replay access code for Amarin's Q1 2025 earnings call is 52230. Investors can access the replay by dialing 877-481-4010 (US) or 919-882-2331 (International).

Who will present at Amarin's Q1 2025 earnings conference call?

Aaron Berg, President & CEO, along with members of Amarin's senior management team will present and host a Q&A session during the Q1 2025 earnings conference call.

Where can investors find Amarin's Q1 2025 earnings call replay?

Investors can access Amarin's Q1 2025 earnings call replay through the company's website at www.amarincorp.com or by using the provided dial-in numbers and replay access code.
Amarin

NASDAQ:AMRN

AMRN Rankings

AMRN Latest News

AMRN Latest SEC Filings

AMRN Stock Data

285.48M
20.59M
1.88%
18.04%
2.06%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2